Cargando…
Label-free drug discovery
Current drug discovery is dominated by label-dependent molecular approaches, which screen drugs in the context of a predefined and target-based hypothesis in vitro. Given that target-based discovery has not transformed the industry, phenotypic screen that identifies drugs based on a specific phenoty...
Autor principal: | Fang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973898/ https://www.ncbi.nlm.nih.gov/pubmed/24723889 http://dx.doi.org/10.3389/fphar.2014.00052 |
Ejemplares similares
-
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022) -
Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018) -
Drug Discovery of DKK1 Inhibitors
por: Jiang, Hewen, et al.
Publicado: (2022) -
The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010) -
Bioluminescent Zebrafish Transplantation Model for Drug Discovery
por: Hason, Martina, et al.
Publicado: (2022)